A detailed history of Kennedy Capital Management, Inc. transactions in Absci Corp stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 88,622 shares of ABSI stock, worth $267,638. This represents 0.01% of its overall portfolio holdings.

Number of Shares
88,622
Previous 75,981 16.64%
Holding current value
$267,638
Previous $234,000 44.44%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.97 - $4.49 $37,543 - $56,758
12,641 Added 16.64%
88,622 $338,000
Q2 2024

Aug 14, 2024

BUY
$2.92 - $6.58 $37,609 - $84,750
12,880 Added 20.41%
75,981 $234,000
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $215,174 - $362,199
63,101 New
63,101 $358,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $280M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.